Selected research
Industry Research
Moclobemide Industry Research Report 2026
Market perspective
The global Moclobemide market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Moclobemide is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Moclobemide is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Moclobemide is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Moclobemide include Sandoz, Roche, Lunan Pharmaceutical, Viatris, Arrow Pharmaceuticals and Apotex, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Moclobemide market in terms of revenue (US$ million) and, where applicable, sales volume (Tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Moclobemide Market by Company
Sandoz
Roche
Lunan Pharmaceutical
Viatris
Arrow Pharmaceuticals
Apotex
Moclobemide Segment by Type
150mg
300mg
Moclobemide Segment by Application
Hospital
Clinic
Other
Moclobemide Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Moclobemide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Moclobemide and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Moclobemide.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Moclobemide manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Moclobemide by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Moclobemide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 150mg
- 300mg
Applications
- Hospital
- Clinic
- Other
Companies covered
- Sandoz
- Roche
- Lunan Pharmaceutical
- Viatris
- Arrow Pharmaceuticals
- Apotex
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Moclobemide Market Size (2021-2032)
- 2.2.2 Global Moclobemide Sales (2021-2032)
- 2.2.3 Global Moclobemide Market Average Price (2021-2032)
- 2.3 Moclobemide by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 150mg
- 2.3.3 300mg
- 2.4 Moclobemide by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Clinic
- 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Moclobemide Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Moclobemide Sales (Tons) of Manufacturers (2021-2026)
- 3.3 Global Moclobemide Revenue of Manufacturers (2021-2026)
- 3.4 Global Moclobemide Average Price by Manufacturers (2021-2026)
- 3.5 Global Moclobemide Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Moclobemide, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Moclobemide, Product Type & Application
- 3.8 Global Manufacturers of Moclobemide, Established Date
- 3.9 Global Moclobemide Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Sandoz
- 4.1.1 Sandoz Company Information
- 4.1.2 Sandoz Business Overview
- 4.1.3 Sandoz Moclobemide Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Sandoz Moclobemide Product Portfolio
- 4.1.5 Sandoz Recent Developments
- 4.2 Roche
- 4.2.1 Roche Company Information
- 4.2.2 Roche Business Overview
- 4.2.3 Roche Moclobemide Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Roche Moclobemide Product Portfolio
- 4.2.5 Roche Recent Developments
- 4.3 Lunan Pharmaceutical
- 4.3.1 Lunan Pharmaceutical Company Information
- 4.3.2 Lunan Pharmaceutical Business Overview
- 4.3.3 Lunan Pharmaceutical Moclobemide Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Lunan Pharmaceutical Moclobemide Product Portfolio
- 4.3.5 Lunan Pharmaceutical Recent Developments
- 4.4 Viatris
- 4.4.1 Viatris Company Information
- 4.4.2 Viatris Business Overview
- 4.4.3 Viatris Moclobemide Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Viatris Moclobemide Product Portfolio
- 4.4.5 Viatris Recent Developments
- 4.5 Arrow Pharmaceuticals
- 4.5.1 Arrow Pharmaceuticals Company Information
- 4.5.2 Arrow Pharmaceuticals Business Overview
- 4.5.3 Arrow Pharmaceuticals Moclobemide Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Arrow Pharmaceuticals Moclobemide Product Portfolio
- 4.5.5 Arrow Pharmaceuticals Recent Developments
- 4.6 Apotex
- 4.6.1 Apotex Company Information
- 4.6.2 Apotex Business Overview
- 4.6.3 Apotex Moclobemide Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Apotex Moclobemide Product Portfolio
- 4.6.5 Apotex Recent Developments
5 Global Moclobemide Market Scenario by Region
- 5.1 Global Moclobemide Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Moclobemide Sales by Region: 2021-2032
- 5.2.1 Global Moclobemide Sales by Region: 2021-2026
- 5.2.2 Global Moclobemide Sales by Region: 2027-2032
- 5.3 Global Moclobemide Revenue by Region: 2021-2032
- 5.3.1 Global Moclobemide Revenue by Region: 2021-2026
- 5.3.2 Global Moclobemide Revenue by Region: 2027-2032
- 5.4 North America Moclobemide Market Facts & Figures by Country
- 5.4.1 North America Moclobemide Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Moclobemide Sales by Country (2021-2032)
- 5.4.3 North America Moclobemide Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Moclobemide Market Facts & Figures by Country
- 5.5.1 Europe Moclobemide Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Moclobemide Sales by Country (2021-2032)
- 5.5.3 Europe Moclobemide Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Moclobemide Market Facts & Figures by Country
- 5.6.1 Asia Pacific Moclobemide Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Moclobemide Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Moclobemide Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Moclobemide Market Facts & Figures by Country
- 5.7.1 South America Moclobemide Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Moclobemide Sales by Country (2021-2032)
- 5.7.3 South America Moclobemide Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.7.7 Colombia
- 5.8 Middle East and Africa Moclobemide Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Moclobemide Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Moclobemide Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Moclobemide Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Moclobemide Sales by Type (2021-2032)
- 6.1.1 Global Moclobemide Sales by Type (2021-2032) & (Tons)
- 6.1.2 Global Moclobemide Sales Market Share by Type (2021-2032)
- 6.2 Global Moclobemide Revenue by Type (2021-2032)
- 6.2.1 Global Moclobemide Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Moclobemide Revenue Market Share by Type (2021-2032)
- 6.3 Global Moclobemide Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Moclobemide Sales by Application (2021-2032)
- 7.1.1 Global Moclobemide Sales by Application (2021-2032) & (Tons)
- 7.1.2 Global Moclobemide Sales Market Share by Application (2021-2032)
- 7.2 Global Moclobemide Revenue by Application (2021-2032)
- 7.2.1 Global Moclobemide Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Moclobemide Revenue Market Share by Application (2021-2032)
- 7.3 Global Moclobemide Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Moclobemide Value Chain Analysis
- 8.1.1 Moclobemide Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Moclobemide Production Mode & Process
- 8.2 Moclobemide Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Moclobemide Distributors
- 8.2.3 Moclobemide Customers
9 Global Moclobemide Analyzing Market Dynamics
- 9.1 Moclobemide Industry Trends
- 9.2 Moclobemide Industry Drivers
- 9.3 Moclobemide Industry Opportunities and Challenges
- 9.4 Moclobemide Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst